Increasing evidences suggest that DEPDC1 appears to be involved in the regulation of carcinogenesis and progression of HCC and represents a potential therapeutic and preventive target of HCC (Qu et al., 2018; Amisaki et al., 2019). This evidence concerns the gene DEPDC1 and hepatocellular carcinoma.